SUBJECT: JPAG Symposium: Stability V: Challenges of in-use stability demonstration / Thursday 25th March 2021 / VIRTUAL EVENT : 1pm-4pm (UK GMT)
EVENT LINK: https://www.jpag.org/140
Continuing our successful series of stability meetings, this event is essential for anyone concerned with the management and assessment of drug stability in-use. We have a group of expert speakers on in-use stability topics from the regulator, the industry and the NHS end user to give a background of their in-use stability perspectives and provide examples of practical issues they have had to face in their every day work.
• Hear about the regulation of in-use stability.
• Learn from industry experts about the challenges they face to meet in-use stability regulations with case studies
• Examine ways the NHS has to work with this data in the "real world" setting and learn about the NHS standards
The meeting will continue with the speakers forming a workshop style panel to debate a selection of hypothetical examples, practical issues, compliance and many more nuances of the in-use stability topic.
ORGANISED BY: Joint Pharmaceutical Analysis Group
WEB LINK: https://www.jpag.org/
SPONSORS: Royal Pharmaceutical Society and Royal Society of Chemistry
CONTACT: Hon Events Secretary JPAG, events@jpag.org
SPEAKERS:
Miles Ambler - GlaxoSmithKline
Bridget Bulwer - Glycostem
Dr Laura Davies - Newcastle upon Tyne Hospitals NHS Foundation Trust
Dr Paul Marshall - Jazz Pharma
Comments